Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Hologic Stories

2013-04-29 20:21:38

QUEBEC CITY, April 29, 2013 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) is pleased to announce that Dr. Yves Fradet, Dr. Louise Proulx, Mr. Andrew Sheldon, Dr. Jacques Simoneau, and Dr. Vincent R. Zurawski, were re-elected by shareholders at the 2013 annual and special meeting of shareholders, held today in Montreal. Shareholders also reappointed Ernst & Young as auditors of the company, approved and ratified amendments to the articles of DiagnoCure, approved and...

2013-04-29 08:27:19

QUEBEC CITY, April 29, 2013 /PRNewswire/ - DiagnoCure Inc. (TSX: CUR) (OTCQX: DGCRF) reminds shareholders to attend its Annual and Special Meeting of Shareholders to be held today, April 29(th), at 3pm EDT, at the offices of McCarthy Tetrault, 1000 de la Gauchetiere Street West, Suite 2500, Montreal, Quebec, H3B 0A2. At the completion of the formal business portion of the meeting, Dr. Yves Fradet, President and Chief Medical Officer will make a presentation during which he will touch...

2013-04-17 23:00:28

Dr. Roehrig to Focus on Strategic Product Development for Volpara Breast Density Measurement Software WELLINGTON, New Zealand (PRWEB) April 17, 2013 Matakina International, leaders in the development of objective volumetric measurement of breast density, announced that breast imaging pioneer Jimmy Roehrig, Ph.D. has joined Matakina, providing scientific depth to the U.S. sales effort, and strategic planning for product development and intellectual property. “After knowing Ralph...

2013-04-16 16:24:35

Breast cancer screening with tomosynthesis finds cancers missed by 2D screening alone utilizing the double read with arbitration approach used in many countries of the world BEDFORD, Mass., April 16, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that a new study published...

2013-04-09 08:30:18

QUEBEC CITY, April 9, 2013 /PRNewswire/ - In view of the annual and special meeting of its shareholders on April 29, 2013, DiagnoCure Inc. (TSX: CUR; OTCQX: DGCRF) (the "Corporation") announces the adoption by its board of directors of an advance notice policy establishing conditions and framework to submit director nominations, similar to what is set forth in the advance notice by-law adopted on March 11, 2013. The advance notice by-law, which is fully described in the...

2013-03-26 16:28:23

BEDFORD, Mass., March 26, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to release its second quarter fiscal 2013 operating results on Monday, May 6, 2013, after market close. In conjunction with the release, management will host a conference call on Monday, May 6,...

2013-03-22 20:21:14

BEDFORD, Mass., March 22, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the expiration of its offer to exchange (the Exchange Offer) up to $1 billion aggregate principal amount of its 6.25% Senior Notes due 2020 which have been registered under the Securities Act of 1933,...

2013-03-22 16:23:47

BEDFORD, Mass., March 22, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that it has successfully completed its sale of the LIFECODES business unit to Immucor, Inc. Hologic has received $85 million in cash (adjusted for working capital items) with the opportunity to earn a...

2013-03-21 16:25:15

Company to highlight groundbreaking 3D technology and other innovations at international breast health conference BEDFORD, Mass., March 21, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will bring its, "3D Technology: A More Accurate Mammogram " mobile coach tour to the National...

2013-03-19 20:23:23

98% of Providers Interviewed Say They Would Buy 3D Mammography Again BEDFORD, Mass., March 19, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the results of an independent survey by KLAS Research of Hologic 3D mammography sites in the U.S. The in-depth survey,...